SXTC
China Sxt Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.08
+24.00%Margins
Gross margin
17.1%
EBITDA margin
-650.7%
EBIT margin
-996.1%
Net margin
-578.5%
FCF margin
-561.8%
-20.9%
Return on equity
-17.9%
Return on assets
-34.7%
Return on invested capital
0.03x
Asset turnover
-$6.0M
Cash from operations
$2.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026